PubMed

Cost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov model.

König HH, Barry JC.

Br J Ophthalmol. 2004 May;88(5):606-12.PMID: 15090409 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-utility analysis of orthoptic screening in kindergarten: a Markov model based on data from Germany.

König HH, Barry JC.

Pediatrics. 2004 Feb;113(2):e95-108.PMID: 14754978 [PubMed - indexed for MEDLINE]Related articlesFree article

The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation.

Carlton J, Karnon J, Czoski-Murray C, Smith KJ, Marr J.

Health Technol Assess. 2008 Jun;12(25):iii, xi-194. Review.PMID: 18513466 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of the determination of autoantibodies against cyclic citrullinated peptide in the early diagnosis of rheumatoid arthritis.

Konnopka A, Conrad K, Baerwald C, König HH.

Ann Rheum Dis. 2008 Oct;67(10):1399-405. Epub 2008 Jan 11.PMID: 18192304 [PubMed - indexed for MEDLINE]Related articles

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.PMID: 16545208 [PubMed - indexed for MEDLINE]Related articlesFree article

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.PMID: 17999842 [PubMed - indexed for MEDLINE]Related articlesFree article

The cost-effectiveness of testing for hepatitis C in former injecting drug users.

Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.PMID: 16948891 [PubMed - indexed for MEDLINE]Related articlesFree article

A cost-utility analysis of therapy for amblyopia.

Membreno JH, Brown MM, Brown GC, Sharma S, Beauchamp GR.

Ophthalmology. 2002 Dec;109(12):2265-71.PMID: 12466169 [PubMed - indexed for MEDLINE]Related articles

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.PMID: 17999840 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK.

Wolowacz SE, Roskell N, Kelly S, Maciver FM, Brand CS.

Pharmacoeconomics. 2007;25(10):863-79.PMID: 17887807 [PubMed - indexed for MEDLINE]Related articles

Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

Shepherd J, Jones J, Takeda A, Davidson P, Price A.

Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N.

Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. Review.PMID: 16545207 [PubMed - indexed for MEDLINE]Related articlesFree article

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.

Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D.

Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. Review.PMID: 16796930 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.

Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, Golder S, Alfakih K, Bakhai A, Packham C, Cooper N, Abrams K, Eastwood A, Pearman A, Flather M, Gray D, Hall A.

Health Technol Assess. 2005 Jul;9(27):iii-iv, ix-xi, 1-158. Review.PMID: 16022802 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.

Kreck S, Klaus J, Leidl R, von Tirpitz C, Konnopka A, Matschinger H, König HH.

Pharmacoeconomics. 2008;26(4):311-28.PMID: 18370566 [PubMed - indexed for MEDLINE]Related articles

[Cost-effectiveness of screening for amblyopia]

Neubauer AS, Neubauer S.

Klin Monbl Augenheilkd. 2005 Feb;222(2):110-6. German. PMID: 15719314 [PubMed - indexed for MEDLINE]Related articles

A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.

Karnon J, Czoski-Murray C, Smith K, Brand C, Chakravarthy U, Davis S, Bansback N, Beverley C, Bird A, Harding S, Chisholm I, Yang YC.

Health Technol Assess. 2008 Jun;12(27):iii-iv, ix-124.PMID: 18513468 [PubMed - indexed for MEDLINE]Related articlesFree article

Early assessment of the likely cost-effectiveness of a new technology: A Markov model with probabilistic sensitivity analysis of computer-assisted total knee replacement.

Dong H, Buxton M.

Int J Technol Assess Health Care. 2006 Spring;22(2):191-202.PMID: 16571195 [PubMed - indexed for MEDLINE]Related articles

Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).

Michaels JA, Campbell WB, Brazier JE, Macintyre JB, Palfreyman SJ, Ratcliffe J, Rigby K.

Health Technol Assess. 2006 Apr;10(13):1-196, iii-iv. Review.PMID: 16707070 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis.

Fowler RA, Hill-Popper M, Stasinos J, Petrou C, Sanders GD, Garber AM.

J Crit Care. 2003 Sep;18(3):181-91; discussion 191-4.PMID: 14595571 [PubMed - indexed for MEDLINE]Related articles